Aclaris Therapeutics, Inc.·4

Mar 9, 5:56 PM ET

Manion Douglas J. 4

4 · Aclaris Therapeutics, Inc. · Filed Mar 9, 2023

Insider Transaction Report

Form 4
Period: 2023-03-09
Manion Douglas J.
Pres and COO
Transactions
  • Purchase

    Common Stock

    2023-03-09$7.74/sh+6,500$50,2786,500 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION